AGMAX Trademark

Trademark Overview


On Saturday, September 7, 2013, a trademark application was filed for AGMAX with the United States Patent and Trademark Office. The USPTO has given the AGMAX trademark a serial number of 86058412. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, July 16, 2014. This trademark is owned by ECA HEALTHCARE INC.. The AGMAX trademark is filed in the Pharmaceutical Products category with the following description:

Albumin dietary supplements; Alginate dietary supplements; Alkalinity buffer supplements for live coral for use in aquariums; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Antioxidant enriched coffee; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Calcium-based nutrient supplements for live coral for use in aquariums; Casein dietary supplements; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredient...
agmax

General Information


Serial Number86058412
Word MarkAGMAX
Filing DateSaturday, September 7, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, July 16, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAlbumin dietary supplements; Alginate dietary supplements; Alkalinity buffer supplements for live coral for use in aquariums; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Antioxidant enriched coffee; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Calcium-based nutrient supplements for live coral for use in aquariums; Casein dietary supplements; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Enzyme food supplements; Flaxseed dietary supplements; Flaxseed oil dietary supplements; Food supplements; Glucose dietary supplements; Ground flaxseed fiber for use as a dietary supplement; Health food supplements; Herbal supplements; Herbal supplements for sleeping problems; Homeopathic supplements; Human allograft bone and tissue; Human allograft tissue; Human growth hormone; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Lecithin for use as a dietary supplement; Linseed dietary supplements; Linseed oil dietary supplements; Liquid herbal supplements; Liquid nutritional supplement; Liquid protein supplements; Medical adhesive tape; Medical adhesives for binding internal tissue; Medical adhesives for binding wounds; Medical and surgical dressings; Medical and surgical plasters; Medical cleansers for skin and wounds; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical dressings; Medical lubricant, namely, vaginal lubricants; Medical plasters; Medical preparations for slimming purposes; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicinal alcohol; Medicinal creams for skin care; Medicinal drinks; Medicinal hair growth preparations; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal oils; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal radix glycyrrhizae; Medicinal roots; Medicinal tea; Medicines for dental purposes; Medicines for the treatment of gastrointestinal diseases; Mineral nutritional supplements; Non-medicated additives for animal feed for use as nutritional supplements; Nopal cactus juice for use as a nutritional supplement; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritional supplements, namely, carbohydrates in powdered form; Nutritional supplements, namely, probiotic compositions; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganism cultures; Nutritive substances for microorganisms for medical purposes; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Veterinary preparations, namely, antioxidants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 16, 2013
Primary Code005
First Use Anywhere DateThursday, May 8, 2008
First Use In Commerce DateFriday, August 8, 2008

Trademark Owner History


Party NameECA HEALTHCARE INC.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShanghai 201101
CN

Trademark Events


Event DateEvent Description
Wednesday, July 16, 2014ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, July 16, 2014ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 18, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2013NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2013NON-FINAL ACTION WRITTEN
Wednesday, December 18, 2013ASSIGNED TO EXAMINER
Monday, September 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, September 11, 2013NEW APPLICATION ENTERED IN TRAM